Recognizing and Treating HFpEF: How Helpful Are MRAs, ARNi and SGLT2 Inhibitors for Treating Patients? What Have We Learned From The PARADIGM and PARAGON Trials?

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

Confirm Password

About Us
Team
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Recognizing and Treating HFpEF: How Helpful Are MRAs, ARNi and SGLT2 Inhibitors for Treating Patients? What Have We Learned From The PARADIGM and PARAGON Trials?

By San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians FEATURING Barry Greenberg

February 5, 2021

0 Comments

Primer on Diabetes Management

Feat. S. Inzucchi

57:44

University of Colorado Department of Medicine

MythBusters: Cardiac Amyloidosis

Feat. A. Ambardekar

18:43

ASPC 2019 Congress on CVD Prevention

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

Feat. R. DeFronzo

26:01

Cardiology Fiesta 2017

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Feat. R. DeFronzo

13:07

Michelle Kittleson

2021 ADA Highlights: Heart Failure With Reduced Ejection Fraction - …

27:24

Cardiometabolic Health Congress (CMHC)

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Feat. L. Sloan

21:36

NYU Langone

Emerging Therapies in Cardiac Amyloidosis

Feat. M. Hanna

19:30

Nasrien Ibrahim

Hot Topics in Heart Failure ACC.22

12:23

American Heart & Vascular Institute

SGLT2 Inhibitors for HF: Is this Therapy Helpful for Reducing the Ho…

Feat. M. Tipton

10:02

Emory Diabetes Education Training Academy

Insulin Treatment in Patients with Type 2 Diabetes: When to Use Comb…

Feat. G. Umpierrez

13:42

George Bakris

Current Status of Prevention and Treatment of Diabetic Nephropathy

11:50

American Heart & Vascular Institute

New Medications for Heart Failure: SGLT2 Inhibitors and Vericiguat. …

Feat. M. Kittleson

17:44

Rita Jermyn

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

15:25

Javed Butler

SGLT2 Inhibitors and Heart Failure in Type-2 Diabetes Mellitus

16:12

Courage and Innovation Symposium: Heart Failure & Heart Transplantation

The Future of Heart Transplantation: Spurring Innovation, Saving Mor…

Feat. V. Jeevanandam

14:44

26th Annual San Diego Heart Failure Symposium

Broadening Indications for the Use of Angiotensin Receptor Neprilysi…

Feat. C. Yancy

17:23

Northwestern Medicine: 8th Annual Cardiovascular Update

AF and Heart Failure: What’s the Risk? Is Ablation the Answer?

Feat. J. Piccini

88:01

CCM® Therapy

The Comparison and Advantages of the Use of Device Therapy in Heart …

Feat. V. Thohan, G. Tomassoni, R. Doshi, F. Abi-Samra, I. Rao

64:40

CCM® Therapy

CCM® Therapy - Mechanism of Action, Patient Selection and Identifica…

Feat. A. Kaplan, H. Saltzman

17:22

Getinge

IABP case study in Advance Heart Failure

Feat. J. Estep

Login

Login

Join VuMedi

Recognizing and Treating HFpEF: How Helpful Are MRAs, ARNi and SGLT2 Inhibitors for Treating Patients? What Have We Learned From The PARADIGM and PARAGON Trials?

Related Content